APA (7th ed.) Citation

Jenum, A. K., Igland, J., Iversen, M. M., Røssberg, J. I., Strandberg, R. B., Berg, T. J., . . . Forster, R. How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Jenum, Anne Karen, Jannicke Igland, Marjolein Memelink Iversen, Jan Ivar Røssberg, Ragnhild B. Strandberg, Tore Julsrud Berg, Esben Selmer Buhl, and Rachel Forster. How Valid Is a Prescription-based Multimorbidity Index (Rx-risk) in Predicting Mortality in the Outcomes and Multimorbidity In Type 2 Diabetes (OMIT) Study? A Nation-wide Registry-based Cohort Study from Norway. BMJ Publishing Group.

MLA (9th ed.) Citation

Jenum, Anne Karen, et al. How Valid Is a Prescription-based Multimorbidity Index (Rx-risk) in Predicting Mortality in the Outcomes and Multimorbidity In Type 2 Diabetes (OMIT) Study? A Nation-wide Registry-based Cohort Study from Norway. BMJ Publishing Group.